Literature DB >> 25763830

Evaluation of the Effect of Cumulative Operator Experience on Hepatocellular Carcinoma Recurrence after Primary Treatment with Radiofrequency Ablation.

Teng-Yu Lee1, Jaw-Town Lin1, Hsiu J Ho1, Ming-Shiang Wu1, Chun-Ying Wu1.   

Abstract

PURPOSE: To investigate the association between cumulative operator volume and the risk of hepatocellular carcinoma (HCC) recurrence after potentially curative radiofrequency ablation (RFA).
MATERIALS AND METHODS: This study was approved by the Research Ethics Committee. By using the Taiwan National Health Insurance Research Database, 52 096 patients with HCC were identified between July 1, 2004, and December 31, 2011. In total, 2827 patients were selected who underwent potentially curative RFA for newly diagnosed HCC. These patients were grouped into quintiles according to the cumulative operator volumes. Patients in the lowest or the highest quintiles were 1:1 matched according to their propensity scores. Finally, two separate groups, each containing 406 patients, were recruited in the high- and low-volume groups (cumulative operator volume of ≥79 cases and ≤10 cases, respectively). Cumulative incidences of and hazard ratios for HCC recurrence were analyzed after adjusting for competing mortality.
RESULTS: The HCC recurrence rate of the high-volume group was significantly lower than that of the low-volume group (high-volume group 5-year recurrence rate of 65.8%, 95% confidence interval [CI]: 59.5%, 72.1%; low-volume group 5-year recurrence rate of 71.4%, 95% CI: 66.2%, 76.5%; P < .05). In modified Cox regression analysis, the highest cumulative operator volume was independently associated with a decreased risk of HCC recurrence (hazard ratio, 0.80; 95% CI: 0.67, 0.97; P < .05). Multivariable stratified analyses verified the association between the highest cumulative operator volume and decreased HCC recurrence in almost all subgroups.
CONCLUSION: The risk of HCC recurrence could be significantly decreased by experienced RFA operators. Further studies based on cumulative operator volume may be helpful in improving the quality of RFA for HCC.

Entities:  

Mesh:

Year:  2015        PMID: 25763830     DOI: 10.1148/radiol.15141864

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

Review 1.  Percutaneous Thermal Ablation for Hepatocellular Carcinoma.

Authors:  Jeffrey L Weinstein; Muneeb Ahmed
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

2.  Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

Authors:  Teng-Yu Lee; Yao-Chun Hsu; Hsiao-Ching Tseng; Shi-Hang Yu; Jaw-Town Lin; Ming-Shiang Wu; Chun-Ying Wu
Journal:  JAMA Intern Med       Date:  2019-05-01       Impact factor: 21.873

3.  Development of a Searchable Database of Cryoablation Simulations for Use in Treatment Planning.

Authors:  F Edward Boas; Govindarajan Srimathveeravalli; Jeremy C Durack; Elena A Kaye; Joseph P Erinjeri; Etay Ziv; Majid Maybody; Hooman Yarmohammadi; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2017-01-03       Impact factor: 2.740

4.  Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of hepatocellular carcinoma.

Authors:  Jianfeng Wang; Yaoping Shi; Zhibin Bai; Yonggang Li; Longhua Qiu; Guy Johnson; Feng Zhang; Xiaoming Yang
Journal:  Int J Hyperthermia       Date:  2016-09-20       Impact factor: 3.914

5.  Evaluation of the Effect of Operator Experience on Outcome of Hepatic Artery Embolization of Hepatocellular Carcinoma in a Tertiary Cancer Center.

Authors:  Hooman Yarmohammadi; Adrian J Gonzalez-Aguirre; Majid Maybody; Etay Ziv; F Edward Boas; Joseph P Erinjeri; Constantinos T Sofocleous; Stephen B Solomon; George Getrajdman
Journal:  Acad Radiol       Date:  2018-02-01       Impact factor: 3.173

6.  Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.

Authors:  Lu-Hung Lee; Jen-I Hwang; Yu-Chi Cheng; Chun-Ying Wu; Shou-Wu Lee; Sheng-Shun Yang; Hong-Zen Yeh; Chi-Sen Chang; Teng-Yu Lee
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

7.  Electric Ablation with Irreversible Electroporation (IRE) in Vital Hepatic Structures and Follow-up Investigation.

Authors:  Xinhua Chen; Zhigang Ren; Tongyin Zhu; Xiongxin Zhang; Zhiyi Peng; Haiyang Xie; Lin Zhou; Shengyong Yin; Junhui Sun; Shusen Zheng
Journal:  Sci Rep       Date:  2015-11-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.